chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Heat In face; Swollen face; "Slits" for eyes; Rash on arms, face, neck and sides; Hives on arms, face, neck and sides; Missed second dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose), URTICARIA (Hives on arms, face, neck and sides), FEELING HOT (Heat In face), SWELLING FACE (Swollen face) and EYE DISORDER ("Slits" for eyes) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical reported history provided by the reporter.   Concomitant products included GLIPIZIDE, METFORMIN, VERAPAMIL and SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for an unknown indication.  On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced URTICARIA (Hives on arms, face, neck and sides) and RASH (Rash on arms, face, neck and sides). In March 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose). On 17-Mar-2021, the patient experienced FEELING HOT (Heat In face), SWELLING FACE (Swollen face) and EYE DISORDER ("Slits" for eyes). In March 2021, PRODUCT DOSE OMISSION ISSUE (Missed second dose), URTICARIA (Hives on arms, face, neck and sides), FEELING HOT (Heat In face), SWELLING FACE (Swollen face), EYE DISORDER ("Slits" for eyes) and RASH (Rash on arms, face, neck and sides) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment information included, oral prednisone and diphenhydramine was provided.  Patients Chronic or long-standing health condition included diabetes but no recent change in status of chronic condition was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow-up information received on 14-MAY 2021 contains Patient address updated, Patient demographic details and Anatomical location was updated
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 44 days after 1st dose and no 2nd dose yet; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (44 days after 1st dose and no 2nd dose yet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (44 days after 1st dose and no 2nd dose yet). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (44 days after 1st dose and no 2nd dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Unknown) with no associated adverse events.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Red Arm; Hot Arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Red Arm) and VACCINATION SITE WARMTH (Hot Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Arm) and VACCINATION SITE WARMTH (Hot Arm). At the time of the report, VACCINATION SITE ERYTHEMA (Red Arm) and VACCINATION SITE WARMTH (Hot Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Dizziness, Dysarthria, Lip swelling
Clinical narrative: Dizziness; Weakness; Swelling of lips; Swelling of face; Swelling of tongue; Slurry speech; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), LIP SWELLING (Swelling of lips), SWELLING FACE (Swelling of face) and SWOLLEN TONGUE (Swelling of tongue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), LIP SWELLING (Swelling of lips), SWELLING FACE (Swelling of face), SWOLLEN TONGUE (Swelling of tongue) and DYSARTHRIA (Slurry speech). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), SWELLING FACE (Swelling of face), SWOLLEN TONGUE (Swelling of tongue) and DYSARTHRIA (Slurry speech) was resolving and LIP SWELLING (Swelling of lips) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included unspecified blood pressure medication.  No treatment information was provided.  Patient was kept for observation at vaccination center for 30 minutes and then to emergency room  where patient was kept for observation for three hours.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue
Clinical narrative: Dizziness; Weakness; Swelling of lips; Swelling of face; Swelling of tongue; Slurry speech; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), LIP SWELLING (Swelling of lips), SWELLING FACE (Swelling of face) and SWOLLEN TONGUE (Swelling of tongue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), LIP SWELLING (Swelling of lips), SWELLING FACE (Swelling of face), SWOLLEN TONGUE (Swelling of tongue) and DYSARTHRIA (Slurry speech). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), SWELLING FACE (Swelling of face), SWOLLEN TONGUE (Swelling of tongue) and DYSARTHRIA (Slurry speech) was resolving and LIP SWELLING (Swelling of lips) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included unspecified blood pressure medication.  No treatment information was provided.  Patient was kept for observation at vaccination center for 30 minutes and then to emergency room  where patient was kept for observation for three hours.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Neck pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Left arm was throbbing; Fever of 100 degrees F; Headache; Shooting pains in neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Shooting pains in neck), VACCINATION SITE PAIN (Left arm was throbbing), PYREXIA (Fever of 100 degrees F) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0UIB21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 28-Dec-2020.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced NECK PAIN (Shooting pains in neck). On an unknown date, the patient experienced VACCINATION SITE PAIN (Left arm was throbbing), PYREXIA (Fever of 100 degrees F) and HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Shooting pains in neck), VACCINATION SITE PAIN (Left arm was throbbing), PYREXIA (Fever of 100 degrees F) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2020, SARS-CoV-2 test: covid positive (Positive) Tested positive for COVID-19. On 17-Mar-2021, Body temperature: 100 (High) Fever of 100 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Left arm was throbbing; Fever of 100 degrees F; Headache; Shooting pains in neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Shooting pains in neck), VACCINATION SITE PAIN (Left arm was throbbing), PYREXIA (Fever of 100 degrees F) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0UIB21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 28-Dec-2020.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced NECK PAIN (Shooting pains in neck). On an unknown date, the patient experienced VACCINATION SITE PAIN (Left arm was throbbing), PYREXIA (Fever of 100 degrees F) and HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Shooting pains in neck), VACCINATION SITE PAIN (Left arm was throbbing), PYREXIA (Fever of 100 degrees F) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2020, SARS-CoV-2 test: covid positive (Positive) Tested positive for COVID-19. On 17-Mar-2021, Body temperature: 100 (High) Fever of 100 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea
Clinical narrative: Diarrhea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and CHILLS (Chills). At the time of the report, DIARRHOEA (Diarrhea) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment was provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Fatigue, Sluggishness, Somnolence, Vaccination site pain
Clinical narrative: a loss of taste; sore at the injection site; fatigued; drowsy; sluggish; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (drowsy), SLUGGISHNESS (sluggish), AGEUSIA (a loss of taste), VACCINATION SITE PAIN (sore at the injection site) and FATIGUE (fatigued) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced SOMNOLENCE (drowsy), SLUGGISHNESS (sluggish), VACCINATION SITE PAIN (sore at the injection site) and FATIGUE (fatigued). On 23-Mar-2021, the patient experienced AGEUSIA (a loss of taste). At the time of the report, SOMNOLENCE (drowsy), SLUGGISHNESS (sluggish), AGEUSIA (a loss of taste), VACCINATION SITE PAIN (sore at the injection site) and FATIGUE (fatigued) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Covid-19 positive after first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 positive after first dose) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced COVID-19 (Covid-19 positive after first dose). At the time of the report, COVID-19 (Covid-19 positive after first dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, SARS-CoV-2 test: positive (Positive) COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment medication were reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: Sneezing all day; Runny nose all day; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing all day) and RHINORRHOEA (Runny nose all day) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced SNEEZING (Sneezing all day) and RHINORRHOEA (Runny nose all day). On 22-Mar-2021, SNEEZING (Sneezing all day) and RHINORRHOEA (Runny nose all day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: TCR received and contains No New Information.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: Red face; Rash all over her body; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red face) and RASH (Rash all over her body) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history information was reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced ERYTHEMA (Red face) and RASH (Rash all over her body). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Red face) and RASH (Rash all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Patient Demographics was added and Date of birth was added
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Scheduled for 2nd dose on 06Mar2021 but he missed it; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Scheduled for 2nd dose on 06Mar2021 but he missed it) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Scheduled for 2nd dose on 06Mar2021 but he missed it). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Scheduled for 2nd dose on 06Mar2021 but he missed it) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Upon internal review on 24-May-2021, age was corrected to unknown.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental exposure to product, Eye irritation, Ocular hyperaemia, Visual impairment
Clinical narrative: eye is red; eye is burning; visual issues; vaccine squirted in her eye; This spontaneous case was reported by a nurse and describes the occurrence of OCULAR HYPERAEMIA (eye is red), EYE IRRITATION (eye is burning), VISUAL IMPAIRMENT (visual issues) and ACCIDENTAL EXPOSURE TO PRODUCT (vaccine squirted in her eye) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced OCULAR HYPERAEMIA (eye is red), EYE IRRITATION (eye is burning), VISUAL IMPAIRMENT (visual issues) and ACCIDENTAL EXPOSURE TO PRODUCT (vaccine squirted in her eye). On 23-Mar-2021, ACCIDENTAL EXPOSURE TO PRODUCT (vaccine squirted in her eye) had resolved. At the time of the report, OCULAR HYPERAEMIA (eye is red), EYE IRRITATION (eye is burning) and VISUAL IMPAIRMENT (visual issues) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment medications were reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Chills; Fever; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body ache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006821A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body ache). At the time of the report, PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This spontaneous case was reported by a health care professional and describes the occurrence of VERTIGO (Vertigo) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VERTIGO (Vertigo). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and AMOXICILLIN for Adverse event, at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Lymphadenopathy, Pain, Vaccination site mass, Vaccination site pain
Clinical narrative: Worried; (Ball) hurts; Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes; Itchy in the injection zone; Little bumps in the injection zone; Pain in the injection zone; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Worried), PAIN ((Ball) hurts), VACCINATION SITE MASS (Little bumps in the injection zone), LYMPHADENOPATHY (Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes) and VACCINATION SITE PRURITUS (Itchy in the injection zone) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN B12 [VITAMIN B12 NOS], MULTIVITAMINS [VITAMINS NOS], COLECALCIFEROL (D3 VITAMIN) and BIOTIN for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain in the injection zone). On 22-Mar-2021, the patient experienced VACCINATION SITE MASS (Little bumps in the injection zone) and VACCINATION SITE PRURITUS (Itchy in the injection zone). On 23-Mar-2021, the patient experienced ANXIETY (Worried), PAIN ((Ball) hurts) and LYMPHADENOPATHY (Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes). At the time of the report, ANXIETY (Worried), PAIN ((Ball) hurts), VACCINATION SITE MASS (Little bumps in the injection zone), LYMPHADENOPATHY (Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes), VACCINATION SITE PRURITUS (Itchy in the injection zone) and VACCINATION SITE PAIN (Pain in the injection zone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Worried; (Ball) hurts; Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes; Itchy in the injection zone; Little bumps in the injection zone; Pain in the injection zone; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Worried), PAIN ((Ball) hurts), VACCINATION SITE MASS (Little bumps in the injection zone), LYMPHADENOPATHY (Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes) and VACCINATION SITE PRURITUS (Itchy in the injection zone) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN B12 [VITAMIN B12 NOS], MULTIVITAMINS [VITAMINS NOS], COLECALCIFEROL (D3 VITAMIN) and BIOTIN for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain in the injection zone). On 22-Mar-2021, the patient experienced VACCINATION SITE MASS (Little bumps in the injection zone) and VACCINATION SITE PRURITUS (Itchy in the injection zone). On 23-Mar-2021, the patient experienced ANXIETY (Worried), PAIN ((Ball) hurts) and LYMPHADENOPATHY (Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes). At the time of the report, ANXIETY (Worried), PAIN ((Ball) hurts), VACCINATION SITE MASS (Little bumps in the injection zone), LYMPHADENOPATHY (Has a little ball, and a little higher there is another ball in her neck in the left side/Inflammed nodes), VACCINATION SITE PRURITUS (Itchy in the injection zone) and VACCINATION SITE PAIN (Pain in the injection zone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acne, Hypersensitivity, Injection site erythema, Pruritus
Clinical narrative: arm got red, it started getting redder and redder; pimples on arms; extremely itchy, getting larger and itchier; had packets of red pactches across his chest and torso migrating down to his calves; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE ERYTHEMA (arm got red, it started getting redder and redder), ACNE (pimples on arms), PRURITUS (extremely itchy, getting larger and itchier) and HYPERSENSITIVITY (had packets of red pactches across his chest and torso migrating down to his calves) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 031L20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included CICLOSPORIN (RESTASIS) and BRIMONIDINE TARTRATE, TIMOLOL MALEATE (COMBIGAN) for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (arm got red, it started getting redder and redder), ACNE (pimples on arms), PRURITUS (extremely itchy, getting larger and itchier) and HYPERSENSITIVITY (had packets of red pactches across his chest and torso migrating down to his calves). At the time of the report, INJECTION SITE ERYTHEMA (arm got red, it started getting redder and redder), ACNE (pimples on arms), PRURITUS (extremely itchy, getting larger and itchier) and HYPERSENSITIVITY (had packets of red pactches across his chest and torso migrating down to his calves) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was on blood pressure medications.  Patient was treated with  ice packs and OTC anti-itch cream.  Patient received the second vaccine and did not have symptoms until around day 7 when his arm got red, it started getting redder and redder and developed pimpleson his arm. It was extremely itchy. It kept getting larger and itchier even after applying ice packs and he couln't sleep so he went to the ED and was treated for an acute allergic reaction. He had packets of red pactches across his chest and torso migrating down to his calves. All of the red areas were covered with pimples. He was sent home with medication and the red and itchy areas aren't growing any longer.   Caller went to hospital ED.    This case was linked to MOD-2021-054764 (Patient Link).
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Tachycardia
Clinical narrative: Tachycardia; Nausea; Fatigue; Body aches; Headache; This spontaneous case was reported by a patient and describes the occurrence of TACHYCARDIA (Tachycardia), NAUSEA (Nausea), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced TACHYCARDIA (Tachycardia), NAUSEA (Nausea), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, TACHYCARDIA (Tachycardia), NAUSEA (Nausea), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient not taking any medication.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 006M20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included ESCITALOPRAM, LAMOTRIGINE and CLONAZEPAM for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, SARS-CoV-2 test: positive (Positive) positive.         Patient called on  23March 2021 to report testing positive for COVID-19 after completing the Moderna COVID-19 vaccination series.    According to patient, two of her family members who have not been vaccinated tested positive for COVID-19 and that is why she went to get tested. She did the test yesterday and got the results as positive today.    Patient asked if she the vaccine can give her the virus and why did she tested positive if she has completed the series and has antibodies.  No treatment information were provided.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: the vaccine came out of the syringe while it was being administered to the patient; the vaccine came out of the syringe while it was being administered to the patient; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (the vaccine came out of the syringe while it was being administered to the patient) and DEVICE CONNECTION ISSUE (the vaccine came out of the syringe while it was being administered to the patient) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced UNDERDOSE (the vaccine came out of the syringe while it was being administered to the patient) and DEVICE CONNECTION ISSUE (the vaccine came out of the syringe while it was being administered to the patient). On 23-Mar-2021, UNDERDOSE (the vaccine came out of the syringe while it was being administered to the patient) and DEVICE CONNECTION ISSUE (the vaccine came out of the syringe while it was being administered to the patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was not provided.  No treatment information was provided.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fatigue, Feeling hot, Hyperhidrosis
Clinical narrative: sweating; Feeling hot; Sleeping a lot; cold sweating; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), FEELING HOT (Feeling hot), HYPERSOMNIA (Sleeping a lot), COLD SWEAT (cold sweating) and FATIGUE (Fatigue) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), FEELING HOT (Feeling hot), HYPERSOMNIA (Sleeping a lot), COLD SWEAT (cold sweating), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (sweating), FEELING HOT (Feeling hot), HYPERSOMNIA (Sleeping a lot), COLD SWEAT (cold sweating), FATIGUE (Fatigue) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.  It was reported the side effects lasted for about 5 days and on 22-MAR-2021 the patient felt much better and did not take anything to alleviate the symptoms
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia
Clinical narrative: sweating; Feeling hot; Sleeping a lot; cold sweating; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), FEELING HOT (Feeling hot), HYPERSOMNIA (Sleeping a lot), COLD SWEAT (cold sweating) and FATIGUE (Fatigue) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), FEELING HOT (Feeling hot), HYPERSOMNIA (Sleeping a lot), COLD SWEAT (cold sweating), FATIGUE (Fatigue) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (sweating), FEELING HOT (Feeling hot), HYPERSOMNIA (Sleeping a lot), COLD SWEAT (cold sweating), FATIGUE (Fatigue) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.  It was reported the side effects lasted for about 5 days and on 22-MAR-2021 the patient felt much better and did not take anything to alleviate the symptoms
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Headache, Illness
Clinical narrative: extremely ill starting on the 18mar2021; joint stiffness; mild cough; sore throat; unbearable itching like crazy at injection site; extreme shivering; Temperature 99.8; intense headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (extremely ill starting on the 18mar2021), JOINT STIFFNESS (joint stiffness), COUGH (mild cough), OROPHARYNGEAL PAIN (sore throat) and INJECTION SITE PRURITUS (unbearable itching like crazy at injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ILLNESS (extremely ill starting on the 18mar2021), JOINT STIFFNESS (joint stiffness), COUGH (mild cough), OROPHARYNGEAL PAIN (sore throat), INJECTION SITE PRURITUS (unbearable itching like crazy at injection site), CHILLS (extreme shivering), PYREXIA (Temperature 99.8) and HEADACHE (intense headache). At the time of the report, ILLNESS (extremely ill starting on the 18mar2021), JOINT STIFFNESS (joint stiffness), COUGH (mild cough), OROPHARYNGEAL PAIN (sore throat), INJECTION SITE PRURITUS (unbearable itching like crazy at injection site), CHILLS (extreme shivering), PYREXIA (Temperature 99.8) and HEADACHE (intense headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 99.8 High. On 19-Mar-2021, SARS-CoV-2 test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Joint stiffness, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: extremely ill starting on the 18mar2021; joint stiffness; mild cough; sore throat; unbearable itching like crazy at injection site; extreme shivering; Temperature 99.8; intense headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (extremely ill starting on the 18mar2021), JOINT STIFFNESS (joint stiffness), COUGH (mild cough), OROPHARYNGEAL PAIN (sore throat) and INJECTION SITE PRURITUS (unbearable itching like crazy at injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ILLNESS (extremely ill starting on the 18mar2021), JOINT STIFFNESS (joint stiffness), COUGH (mild cough), OROPHARYNGEAL PAIN (sore throat), INJECTION SITE PRURITUS (unbearable itching like crazy at injection site), CHILLS (extreme shivering), PYREXIA (Temperature 99.8) and HEADACHE (intense headache). At the time of the report, ILLNESS (extremely ill starting on the 18mar2021), JOINT STIFFNESS (joint stiffness), COUGH (mild cough), OROPHARYNGEAL PAIN (sore throat), INJECTION SITE PRURITUS (unbearable itching like crazy at injection site), CHILLS (extreme shivering), PYREXIA (Temperature 99.8) and HEADACHE (intense headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 99.8 High. On 19-Mar-2021, SARS-CoV-2 test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chromaturia, Decreased appetite, Dizziness, Fatigue, Headache
Clinical narrative: Pee has change its color, it is like bloodier, darker and reddish; Dizziness; Did not have any appetite; Itchiness in different part of their body at different moments (feet, legs, chest, back); Throat is closing some times, like when one gets the flu; Tired; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHROMATURIA (Pee has change its color, it is like bloodier, darker and reddish), DIZZINESS (Dizziness), DECREASED APPETITE (Did not have any appetite), PRURITUS (Itchiness in different part of their body at different moments (feet, legs, chest, back)) and OROPHARYNGEAL DISCOMFORT (Throat is closing some times, like when one gets the flu) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHROMATURIA (Pee has change its color, it is like bloodier, darker and reddish), DIZZINESS (Dizziness), DECREASED APPETITE (Did not have any appetite), PRURITUS (Itchiness in different part of their body at different moments (feet, legs, chest, back)), OROPHARYNGEAL DISCOMFORT (Throat is closing some times, like when one gets the flu), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, CHROMATURIA (Pee has change its color, it is like bloodier, darker and reddish), DIZZINESS (Dizziness), DECREASED APPETITE (Did not have any appetite), PRURITUS (Itchiness in different part of their body at different moments (feet, legs, chest, back)), OROPHARYNGEAL DISCOMFORT (Throat is closing some times, like when one gets the flu), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment information were not reported.   This case was linked to MOD-2021-054925 (E2B Linked Report).; Sender's Comments:  MOD-2021-054925:Same reporter; Primary reporter case
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Pruritus
Clinical narrative: Pee has change its color, it is like bloodier, darker and reddish; Dizziness; Did not have any appetite; Itchiness in different part of their body at different moments (feet, legs, chest, back); Throat is closing some times, like when one gets the flu; Tired; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHROMATURIA (Pee has change its color, it is like bloodier, darker and reddish), DIZZINESS (Dizziness), DECREASED APPETITE (Did not have any appetite), PRURITUS (Itchiness in different part of their body at different moments (feet, legs, chest, back)) and OROPHARYNGEAL DISCOMFORT (Throat is closing some times, like when one gets the flu) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHROMATURIA (Pee has change its color, it is like bloodier, darker and reddish), DIZZINESS (Dizziness), DECREASED APPETITE (Did not have any appetite), PRURITUS (Itchiness in different part of their body at different moments (feet, legs, chest, back)), OROPHARYNGEAL DISCOMFORT (Throat is closing some times, like when one gets the flu), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, CHROMATURIA (Pee has change its color, it is like bloodier, darker and reddish), DIZZINESS (Dizziness), DECREASED APPETITE (Did not have any appetite), PRURITUS (Itchiness in different part of their body at different moments (feet, legs, chest, back)), OROPHARYNGEAL DISCOMFORT (Throat is closing some times, like when one gets the flu), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment information were not reported.   This case was linked to MOD-2021-054925 (E2B Linked Report).; Sender's Comments:  MOD-2021-054925:Same reporter; Primary reporter case
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chills, Pain in extremity, Tremor, Vomiting
Clinical narrative: Vomited 3 times; Whole body started trembling and could not stop it; Severe chills/still freezing; A little bit of arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little bit of arm pain), TREMOR (Whole body started trembling and could not stop it), CHILLS (Severe chills/still freezing) and VOMITING (Vomited 3 times) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Splenectomy (5-6 years ago had his spleen remove to stop proteins from attaching to his platelets.). Concurrent medical conditions included CLL (10 years now). Concomitant products included METFORMIN and INSULIN GLARGINE (LANTUS) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (A little bit of arm pain). On 16-Mar-2021, the patient experienced TREMOR (Whole body started trembling and could not stop it) and CHILLS (Severe chills/still freezing). On 17-Mar-2021 at 2:00 AM, the patient experienced VOMITING (Vomited 3 times). At the time of the report, PAIN IN EXTREMITY (A little bit of arm pain), TREMOR (Whole body started trembling and could not stop it) and CHILLS (Severe chills/still freezing) outcome was unknown and VOMITING (Vomited 3 times) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Blood test: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not reported. Concomitant medication includes- ultra 2 vitamins. Patient weight-213
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: received first vaccination on 07 Feb 2021; not able to schedule the second appointment due to no vacant spaces; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received first vaccination on 07 Feb 2021; not able to schedule the second appointment due to no vacant spaces) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (received first vaccination on 07 Feb 2021; not able to schedule the second appointment due to no vacant spaces). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received first vaccination on 07 Feb 2021; not able to schedule the second appointment due to no vacant spaces) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.   This case was linked to MOD21-060091 (Patient Link).   Reporter did not allow further contact